A consortium of researchers with multidisciplinary skills, coordinated by INRAE and including the CNRS, the Université ...

The executive order aims to lower prescription prices, but targets the mechanism for negotiating small molecule drug costs.

The president said he would build on the Medicare drug-price negotiation program begun under Joe Biden, but supports a change ...

According to KFF, the new executive order directs the Department of Health and Human Services to work with Congress to ...

A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing ...

A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the ...

Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...

Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...

Researchers have made a breakthrough discovery that could potentially revolutionize treatments for antibiotic-resistant infections, cancer and other challenging gram-negative pathogens without relying ...

The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the ...

Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.

President Donald Trump signed an executive order into law that aims to provide access to prescription drugs at lower costs to ...